Summary

The global medical image analysis software market is projected to reach USD 6.42 billion by 2031 from USD 4.35 billion in 2026, at a CAGR of 8.1%. Market growth is mainly driven by the rising need to reduce radiologist workload across detection, segmentation, reconstruction, and reporting workflows. Hospitals are using AI-based software to triage urgent findings, reduce interpretation time, and manage rising CT, MRI, ultrasound, and mammography volumes. Diagnostic imaging centers are adopting cloud-based platforms to improve report turnaround and support remote reading across multiple sites. Academic and research institutions are increasingly relying on AI software for multi-center clinical studies and disease-specific research as imaging datasets grow larger and more complex. The market is further supported by integrated AI-enabled hardware, deep learning algorithms, cloud-native platforms, and enterprise imaging acquisitions that help reduce cost and improve diagnostic turnaround time. Deep learning accounted for the largest share of the AI-enabled technology market in 2025. By AI-enabled technology, the medical image analysis software market is segmented into machine learning, deep learning, computer vision, and natural language processing. The deep learning segment accounted for the largest market share in 2025, as radiology AI vendors continue to build convolutional neural network-based models for detecting fractures, tumors, strokes, and other abnormalities directly from raw pixel data. This segment includes automated lesion detection, image segmentation, quantitative measurement, and abnormality classification. Adoption is especially strong because deep learning models can be trained on large, multi-institutional imaging datasets and validated for FDA clearance faster than older rule-based approaches. Diagnostic imaging centers are expected to register the fastest growth among end users during the forecast period. Based on end user, the medical image analysis software market is segmented into hospitals, diagnostic imaging centers, academic and research institutions, and other end users. Among these, diagnostic imaging centers are expected to record the fastest growth during the forecast period. The growth is mainly driven by rising outpatient imaging volumes, the need for faster report turnaround, and increasing use of AI to support remote and teleradiology reading models. Diagnostic imaging centers are increasingly using AI-based triage and reporting software because they process high volumes of standardized scans with limited on-site radiologist staff. As outpatient imaging demand rises and centers compete on turnaround time, AI-based detection and workflow software is becoming a priority investment area to protect margins and improve patient throughput. Asia Pacific to witness the highest growth rate in the medical image analysis software market during the forecast period. Asia Pacific is expected to witness the highest growth rate in the medical image analysis software market during the forecast period. The growth is mainly supported by rising healthcare digitization, expanding private hospital networks, growing insurance coverage, and a severe shortage of radiologists relative to imaging demand. Countries such as India, China, Japan, South Korea, Australia, and the Philippines are becoming important markets as healthcare organizations try to manage higher patient volumes, reduce diagnostic delays, and improve access to specialist imaging review in rural and tier-2/tier-3 areas. India faces a critical radiologist shortage, with estimates suggesting fewer than one radiologist per 100,000 people in rural areas. India's Ayushman Bharat Digital Mission is also building the digital infrastructure needed for connected health records, having created 799 million digital health IDs and linked 410,000 healthcare facilities as of August 2025, which can increase demand for cloud-based, AI-enabled imaging software over time. Asia Pacific is also a strong delivery hub for medical imaging AI because of its large skilled technical workforce, cost-efficient software development, and growing base of homegrown AI radiology vendors. Qure.ai, an Indian AI radiology company, was recognized in 2025 by Time Magazine as one of the world's most influential AI healthcare companies, deploying its solutions in over 100 countries with multiple FDA clearances. The breakdown of primary participants is as given below: ・By Company Type - Tier 1: 60%, Tier 2: 30%, and Tier 3: 10% ・By Designation - C-level: 30%, Director-level: 50%, and Others: 20% ・By Region - North America: 45%, Europe: 20%, Asia Pacific: 25%, Rest of the world: 10%. Siemens Healthineers AG (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), FUJIFILM Holdings Corporation (Japan), and Aidoc Medical Ltd. (Israel) are key players in the medical image analysis software market. The study includes an in-depth competitive analysis of these key players in the medical image analysis software market, with their company profiles, recent developments, and key market strategies. Research Coverage This research report categorizes the medical image analysis software market by Type [Integrated Software, Standalone Software], Technology [AI-Enabled Technology {Machine Learning, Deep Learning, Computer Vision, Natural Language Processing}, Conventional Technology], Function [Reconstruction & Visualization, Detection & Localization, Segmentation & Analysis, Registration & Comparison, Reporting & Communication, Clinical Decision Support], Image Type [2D Imaging, 3D Imaging, 4D Imaging], Modality [Radiography (X-Ray), Computed Tomography (CT) {High-end Slice CT, Mid-end Slice CT, Low-end Slice CT}, Magnetic Resonance Imaging (MRI) {Closed MRI Systems, Open MRI Systems}, Ultrasound Imaging {2D Ultrasound Systems, 3D and 4D Ultrasound Systems, Doppler Imaging}, Nuclear Imaging {Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)}, Mammography, Combined/Hybrid Modalities {PET/CT, SPECT/CT, PET/MR}, Others], Therapeutic Area [Cardiology, Oncology, Neurology, Orthopedics, Dental, Obstetrics & Gynecology, Mammography/Breast Imaging, Others], End User [Hospitals, Diagnostic Imaging Centers, Academic & Research Institutions, Other End Users], and Region [North America, Europe, Asia Pacific, Latin America, and Middle East & Africa]. The report covers detailed information on major factors such as drivers, restraints, challenges, and opportunities influencing the growth of the medical image analysis software market. This report provides a detailed analysis of key industry players, including their business overview, product portfolios, technology capabilities, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments in the medical image analysis software market. This report covers a competitive analysis of established and emerging players in the medical image analysis software ecosystem. Reasons to buy this report The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the medical image analysis software market and the subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: ・ The report provides insights on the following pointers: Analysis of key drivers (rising imaging volumes amid growing radiologist workforce shortages, increasing FDA and regulatory clearances for AI-enabled imaging software, growing integration of AI capabilities into imaging hardware systems, rising prevalence of chronic diseases requiring imaging-based diagnosis, increasing venture capital and strategic investment in AI radiology platforms), restraints (high cost of software validation, integration, and deployment, data privacy and cross-border health data regulations), opportunities (expansion of cloud-native and AI-as-a-service imaging platforms, untapped growth potential in emerging markets across Asia Pacific, Latin America, and Middle East & Africa, emerging applications of foundation models and multimodal AI in diagnostic imaging), and challenges (limited interoperability with legacy PACS/RIS and vendor-specific systems, algorithm generalizability and bias across diverse patient populations) influencing the growth of the medical image analysis software market. ・ Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical image analysis software market. ・ Market Development: Comprehensive information about lucrative markets; the report analyses the medical image analysis software market across varied regions. ・ Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical image analysis software market. ・ Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Siemens Healthineers AG (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), FUJIFILM Holdings Corporation (Japan), and Aidoc Medical Ltd. (Israel), among others, in the medical image analysis software market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 42
1.1 STUDY OBJECTIVES 42
1.2 MARKET DEFINITION 42
1.3 MARKET SCOPE 43
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 43
1.3.2 INCLUSIONS AND EXCLUSIONS 44
1.3.3 YEARS CONSIDERED 45
1.4 CURRENCY 46
1.5 STAKEHOLDERS 46
1.6 SUMMARY OF CHANGES 46
2 EXECUTIVE SUMMARY 48
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 48
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 50
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 51
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 52
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 53
3 PREMIUM INSIGHTS 54
3.1 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET OVERVIEW 54
3.2 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE & COUNTRY 55
3.3 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: GEOGRAPHIC SNAPSHOT 55
4 MARKET OVERVIEW 56
4.1 INTRODUCTION 56
4.2 MARKET DYNAMICS 57
4.2.1 DRIVERS 57
4.2.1.1 Rising imaging volumes amid growing radiologist workforce shortages 57
4.2.1.2 Increasing FDA and regulatory clearances for AI-enabled imaging software 58
4.2.1.3 Growing demand for early and accurate disease detection 58
4.2.1.4 Increasing adoption of quantitative and workflow-automation solutions 59
4.2.2 RESTRAINTS 59
4.2.2.1 High cost of software validation, integration, and deployment 59
4.2.2.2 Data privacy and cross-border health data regulations 60
4.2.3 OPPORTUNITIES 60
4.2.3.1 Expansion of cloud-native and AI-as-a-service imaging platforms 60
4.2.3.2 Emerging applications of foundation models and multimodal AI in diagnostic imaging 61
4.2.3.3 Expansion into new imaging modalities and clinical specialties 61
4.2.3.4 Integration of image analysis with clinical decision-support and longitudinal care platforms 61
4.2.4 CHALLENGES 62
4.2.4.1 Limited interoperability with legacy PACS/RIS and vendor-specific systems 62
4.2.4.2 Algorithm generalizability and bias across diverse patient populations 62
4.3 UNMET NEEDS AND WHITE SPACES 63
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 64
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 65
5 INDUSTRY TRENDS 67
5.1 PORTER’S FIVE FORCES ANALYSIS 67
5.1.1 BARGAINING POWER OF SUPPLIERS 68
5.1.2 BARGAINING POWER OF BUYERS 68
5.1.3 THREAT OF SUBSTITUTES 68
5.1.4 THREAT OF NEW ENTRANTS 69
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 69
5.2 MACROECONOMIC INDICATORS 69
5.2.1 INTRODUCTION 69
5.2.2 GDP TRENDS AND FORECAST 70
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 71
5.3 VALUE CHAIN ANALYSIS 72
5.3.1 RESEARCH, IMAGING DATA GENERATION, AND CLINICAL INPUTS 73
5.3.2 DATA ENGINEERING & AI INFRASTRUCTURE 73
5.3.3 AI MODEL & PLATFORM DEVELOPMENT 74
5.3.4 WORKFLOW INTEGRATION & INTEROPERABILITY 74
5.3.5 SOFTWARE DEPLOYMENT & CLINICAL SERVICES 74
5.3.6 CLINICAL VALIDATION, MONITORING, AND CONTINUOUS OPTIMIZATION 74
5.4 ECOSYSTEM ANALYSIS 75
5.5 PRICING ANALYSIS 76
5.5.1 MEDICAL IMAGE ANALYSIS SOFTWARE PLATFORMS, BY KEY PLAYERS (2025) 77
5.5.2 INDICATIVE PRICE FOR MEDICAL IMAGE ANALYSIS SOFTWARE, BY REGION (2025) 78
5.6 KEY CONFERENCES AND EVENTS, 2026–2027 80
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 80
5.8 INVESTMENT AND FUNDING SCENARIO 81
5.9 CASE STUDY ANALYSIS 82
5.10 IMPACT OF 2025 US TARIFF – MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 84
5.10.1 INTRODUCTION 84
5.10.2 KEY TARIFF RATES 85
5.10.3 PRICE IMPACT ANALYSIS 85
5.10.4 IMPACT ON COUNTRY/REGION 86
5.10.4.1 US 86
5.10.4.2 Europe 86
5.10.4.3 Asia Pacific 87
5.10.5 IMPACT ON END USERS 87
5.10.5.1 Hospitals and health systems 87
5.10.5.2 Diagnostic imaging centers 87
5.10.5.3 Specialty clinics and ambulatory care providers 87
5.10.5.4 Pharmaceutical and biotechnology companies 88
5.10.5.5 Academic and research institutions 88
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 89
6.1 KEY EMERGING TECHNOLOGIES 89
6.1.1 AI-POWERED DEEP LEARNING AND FOUNDATION MODELS 89
6.1.2 CLOUD-NATIVE MEDICAL IMAGING AND AI-AS-A-SERVICE 90
6.1.3 ADVANCED 3D VISUALIZATION, SEGMENTATION, AND QUANTITATIVE IMAGING 90
6.2 COMPLEMENTARY TECHNOLOGIES 91
6.2.1 CLOUD COMPUTING AND EDGE COMPUTING 91
6.2.2 INTEROPERABILITY, PACS/VNA, AND CLINICAL DATA INTEGRATION 91
6.3 TECHNOLOGY/PRODUCT ROADMAP 92
6.4 PATENT ANALYSIS 93
6.4.1 PATENT PUBLICATION TRENDS FOR MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 94
6.4.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 95
6.5 FUTURE APPLICATIONS 99
6.5.1 EARLY DISEASE DETECTION AND SCREENING 99
6.5.2 PERSONALIZED TREATMENT PLANNING AND THERAPY GUIDANCE 99
6.5.3 LONGITUDINAL DISEASE MONITORING AND TREATMENT RESPONSE 99
6.6 IMPACT OF AI/GEN AI ON MEDICAL IMAGE ANALYSIS SOFTWARE SOLUTIONS 100
6.6.1 INTRODUCTION 100
6.6.2 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 102
6.6.2.1 AI-powered chest X-ray analysis for tuberculosis screening 102
6.6.3 IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS 103
6.6.3.1 PACS/VNA & enterprise imaging market 103
6.6.3.2 AI in medical imaging market 104
6.6.3.3 EHR/Clinical decision support market 104
6.6.4 USER READINESS & IMPACT ASSESSMENT 104
6.6.4.1 User readiness 104
6.6.4.1.1 User A: Healthcare providers 104
6.6.4.1.2 User B: Diagnostic imaging centers 104
6.6.4.2 Impact assessment 105
6.6.4.2.1 User A: Healthcare providers 105
6.6.4.2.2 User B: Diagnostic imaging centers 105
7 REGULATORY LANDSCAPE 106
7.1 REGIONAL REGULATIONS AND COMPLIANCE 106
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
7.1.2 REGULATORY FRAMEWORK 113
7.1.2.1 North America 113
7.1.2.2 Europe 114
7.1.2.3 ASIA PACIFIC 115
7.1.2.4 LATIN AMERICA 116
7.1.2.5 MIDDLE EAST & AFRICA 117
7.1.3 INDUSTRY STANDARDS 118
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 119
8.1 INTRODUCTION 119
8.2 DECISION-MAKING PROCESS 119
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 120
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 120
8.3.2 BUYING CRITERIA 121
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 122
8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 122
8.5.1 UNMET NEEDS 123
8.5.2 END USER EXPECTATIONS 123
8.6 MARKET PROFITABILITY 124
9 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER 126
9.1 INTRODUCTION 127
9.2 HOSPITALS 127
9.2.1 INCREASING ADOPTION OF ADVANCED MEDICAL IMAGING AND AI IN HOSPITALS 127
9.3 DIAGNOSTIC IMAGING CENTERS 128
9.3.1 RISING DEMAND FOR EFFICIENT AND HIGH-VOLUME DIAGNOSTIC IMAGING TO BOOST MARKET 128
9.4 ACADEMIC & RESEARCH INSTITUTIONS 129
9.4.1 INCREASING USE OF MEDICAL IMAGE ANALYSIS SOFTWARE IN RESEARCH TO BOOST SEGMENT 129
9.5 OTHER END USERS 130
9.5.1 EXPANDING USE OF MEDICAL IMAGE ANALYSIS BEYOND CONVENTIONAL HEALTHCARE SETTING TO BOOST SEGMENT 130
10 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION 132
10.1 INTRODUCTION 133
10.2 RECONSTRUCTION & VISUALIZATION 133
10.2.1 INCREASING DEMAND FOR HIGH-QUALITY IMAGE RECONSTRUCTION AND 3D VISUALIZATION TO BOOST SEGMENT 133
10.3 DETECTION & LOCALIZATION 134
10.3.1 RISING DEMAND FOR AUTOMATED DETECTION AND LOCALIZATION OF ABNORMALITIES 134
10.4 SEGMENTATION & ANALYSIS 135
10.4.1 INCREASING ADOPTION OF AUTOMATED SEGMENTATION AND QUANTITATIVE IMAGE ANALYSIS 135
10.5 REGISTRATION & COMPARISON 136
10.5.1 GROWING NEED FOR ACCURATE ALIGNMENT AND COMPARISON OF MULTIMODAL MEDICAL IMAGES TO BOOST GROWTH 136
10.6 REPORTING & COMMUNICATION 137
10.6.1 GROWING ADOPTION OF AI-POWERED RADIOLOGY REPORTING AND WORKFLOW AUTOMATION TO DRIVE SEGMENT 137
10.7 CLINICAL DECISION SUPPORT 138
10.7.1 INCREASING ADOPTION OF AI-ASSISTED CLINICAL DECISION SUPPORT 138
11 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE 140
11.1 INTRODUCTION 141
11.2 3D IMAGING 141
11.2.1 GROWING ADOPTION OF 3D IMAGING FOR DETAILED ANATOMICAL VISUALIZATION TO BOOST SEGMENT 141
11.3 4D IMAGING 142
11.3.1 GROWING DEMAND FOR DYNAMIC AND FUNCTIONAL MEDICAL IMAGING TO DRIVE SEGMENT 142
11.4 2D IMAGING 143
11.4.1 CONTINUED DEMAND FOR 2D IMAGING IN ROUTINE DIAGNOSTIC APPLICATIONS – KEY DRIVER 143
12 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY 144
12.1 INTRODUCTION 145
12.2 RADIOGRAPHY (X-RAY) 145
12.2.1 INCREASING ADOPTION OF AI-ENABLED X-RAY ANALYSIS AND WORKFLOW AUTOMATION TO DRIVE SEGMENT 145
12.3 COMPUTED TOMOGRAPHY (CT) 146
12.3.1 SEGMENT DRIVEN BY AI-ENABLED CT IMAGE ANALYSIS FOR RECONSTRUCTION AND DETECTION 146
12.3.2 HIGH-END SLICE CT 147
12.3.2.1 Growing demand for high-resolution and advanced CT imaging – key driver 147
12.3.3 MID-END SLICE CT 148
12.3.3.1 Demand for versatile CT systems with automated analysis to boost growth 148
12.3.4 LOW-END SLICE CT 149
12.3.4.1 Expanding access to cost-efficient CT imaging to propel growth 149
12.4 MAGNETIC RESONANCE IMAGING (MRI) 150
12.4.1 INCREASING ADOPTION OF AI-POWERED MRI RECONSTRUCTION AND WORKFLOW AUTOMATION TO DRIVE MARKET 150
12.4.2 CLOSED MRI SYSTEMS 151
12.4.2.1 Increasing demand for high-resolution and AI-optimized MRI to drive segment 151
12.4.3 OPEN MRI SYSTEMS 152
12.4.3.1 Expanding access to patient-friendly and specialized MRI to drive segment 152
12.5 ULTRASOUND IMAGING 153
12.5.1 INCREASING ADOPTION OF AI-POWERED ULTRASOUND IMAGING AND WORKFLOW AUTOMATION TO DRIVE MARKET 153
12.5.2 2D ULTRASOUND SYSTEMS 154
12.5.2.1 Expanding use of AI-assisted analysis in routine 2D ultrasound to drive segment 154
12.5.3 3D & 4D ULTRASOUND SYSTEMS 155
12.5.3.1 Increasing demand for volumetric and dynamic ultrasound analysis to boost segment 155
12.5.4 DOPPLER IMAGING 156
12.5.4.1 Growing demand for automated blood-flow assessment 156
12.6 NUCLEAR IMAGING 157
12.6.1 GROWING ADOPTION OF QUANTITATIVE ANALYSIS IN NUCLEAR IMAGING TO BOOST SEGMENT 157
12.6.2 POSITRON EMISSION TOMOGRAPHY (PET) 158
12.6.2.1 Increasing use of quantitative PET for molecular and functional imaging to drive segment 158
12.6.3 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) 159
12.6.3.1 Growing demand for quantitative SPECT in theranostics and cardiovascular imaging 159
12.7 MAMMOGRAPHY 160
12.7.1 INCREASING ADOPTION OF AI-POWERED MAMMOGRAPHY FOR BREAST CANCER DETECTION TO BOOS SEGMENT 160
12.8 COMBINED/HYBRID MODALITIES 161
12.8.1 GROWING ADOPTION OF HYBRID IMAGING FOR INTEGRATED ANATOMICAL AND FUNCTIONAL ANALYSIS TO BOOST SEGMENT 161
12.8.2 PET/CT 162
12.8.2.1 Increasing demand for quantitative PET/CT in oncology 162
12.8.3 SPECT/CT 163
12.8.3.1 Increasing use of SPECT/CT for quantitative assessment and dosimetry 163
12.8.4 PET/MR 164
12.8.4.1 Growing demand for high-resolution multimodal brain and oncology imaging to propel demand 164
12.9 OTHERS 165
13 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY 167
13.1 INTRODUCTION 168
13.2 AI-ENABLED TECHNOLOGY 168
13.2.1 INCREASING ADOPTION OF AI FOR AUTOMATED AND QUANTITATIVE IMAGE ANALYSIS 168
13.2.2 MACHINE LEARNING 170
13.2.2.1 Increasing use of machine learning for automated medical image analysis to drive segment 170
13.2.3 DEEP LEARNING 171
13.2.3.1 Growing use of deep learning for high-precision medical image reconstruction and analysis to boost segment 171
13.2.4 COMPUTER VISION 172
13.2.4.1 Increasing adoption of computer vision for automated detection and interpretation of medical images to boost segment 172
13.2.5 NATURAL LANGUAGE PROCESSING (NLP) 173
13.2.5.1 Increasing use of NLP for automated radiology reporting and clinical information extraction 173
13.3 CONVENTIONAL TECHNOLOGY 174
13.3.1 CONTINUED DEMAND FOR RELIABLE AND ESTABLISHED IMAGE PROCESSING 174
14 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA 175
14.1 INTRODUCTION 176
14.2 CARDIOLOGY 176
14.2.1 INCREASING ADOPTION OF AI-POWERED CARDIOVASCULAR IMAGE ANALYSIS TO DRIVE MARKET 176
14.3 ONCOLOGY 177
14.3.1 INCREASING USE OF MEDICAL IMAGING AND AI FOR CANCER DETECTION AND TREATMENT MONITORING TO BOOST SEGMENT 177
14.4 NEUROLOGY 178
14.4.1 RISING DEMAND FOR AI-ASSISTED NEUROLOGICAL IMAGING AND EARLY DISEASE DETECTION 178
14.5 ORTHOPEDICS 179
14.5.1 GROWING ADOPTION OF AI-ENABLED IMAGING FOR ORTHOPEDIC DIAGNOSIS AND SURGICAL PLANNING 179
14.6 DENTAL 180
14.6.1 INCREASING ADOPTION OF AI-ENABLED DENTAL IMAGING AND DIAGNOSTIC ANALYSIS TO BOOST SEGMENT 180
14.7 OBSTETRICS & GYNECOLOGY 181
14.7.1 INCREASING ADOPTION OF AI-ENABLED OBSTETRIC AND GYNECOLOGICAL IMAGING 181
14.8 MAMMOGRAPHY/BREAST IMAGING 182
14.8.1 GROWING ADOPTION OF AI FOR BREAST CANCER DETECTION AND MAMMOGRAPHY WORKFLOW OPTIMIZATION 182
14.9 OTHER THERAPEUTIC AREAS 183
14.9.1 EXPANDING APPLICATIONS OF MEDICAL IMAGE ANALYSIS ACROSS EMERGING THERAPEUTIC AREAS 183
15 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE 185
15.1 INTRODUCTION 186
15.2 INTEGRATED SOFTWARE 186
15.2.1 GROWING INTEGRATION OF AI-POWERED IMAGE ANALYSIS INTO CLINICAL WORKFLOWS TO BOOST SEGMENT 186
15.3 STANDALONE SOFTWARE 187
15.3.1 INCREASING ADOPTION OF AI-ENABLED STANDALONE IMAGE ANALYSIS SOLUTIONS TO DRIVE SEGMENT 187
16 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION 189
16.1 INTRODUCTION 190
16.2 NORTH AMERICA 190
16.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 191
16.2.2 US 197
16.2.2.1 Growing demand for faster diagnostics to boost demand 197
16.2.3 CANADA 203
16.2.3.1 Increasing investments in healthcare data infrastructure and medical imaging AI to drive market 203
16.3 EUROPE 209
16.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 210
16.3.2 GERMANY 216
16.3.2.1 Growing adoption of AI-powered medical imaging and radiology solutions to drive market 216
16.3.3 FRANCE 222
16.3.3.1 Increasing adoption of AI-based medical imaging solutions to drive market 222
16.3.4 UK 228
16.3.4.1 Increasing government support for AI-enabled medical imaging to boost market 228
16.3.5 ITALY 234
16.3.5.1 Growing adoption of AI in medical imaging and diagnostic workflows to boost market 234
16.3.6 SPAIN 240
16.3.6.1 Expanding adoption of AI-powered medical imaging solutions to boost market 240
16.3.7 REST OF EUROPE 245
16.4 ASIA PACIFIC 252
16.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 253
16.4.2 CHINA 260
16.4.2.1 Expanding deployment of AI-powered medical imaging solutions to boost market 260
16.4.3 JAPAN 266
16.4.3.1 Growing adoption of AI in medical imaging and radiology to boost market 266
16.4.4 INDIA 272
16.4.4.1 Increasing investment in AI-powered medical imaging and diagnostic infrastructure to drive market 272
16.4.5 AUSTRALIA 278
16.4.5.1 Increasing investment in AI-enabled medical imaging and diagnostic infrastructure 278
16.4.6 SOUTH KOREA 283
16.4.6.1 Strong government and industry investment in AI-enabled medical imaging 283
16.4.7 REST OF ASIA PACIFIC 289
16.5 LATIN AMERICA 295
16.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 296
16.5.2 BRAZIL 302
16.5.2.1 Increasing investment in AI infrastructure and medical imaging to drive market 302
16.5.3 MEXICO 308
16.5.3.1 Increasing deployment of AI-enabled medical imaging infrastructure 308
16.5.4 REST OF LATIN AMERICA 314
16.5.4.1 Growing adoption of AI in medical imaging to boost market 314
16.6 MIDDLE EAST & AFRICA 320
16.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 320
16.6.2 GCC 326
16.6.2.1 Expanding healthcare digitalization and AI adoption to drive market 326
16.6.2.2 Saudi Arabia 332
16.6.2.2.1 Accelerating adoption of AI in medical imaging – key driver 332
16.6.2.3 UAE 339
16.6.2.3.1 Government-led AI initiatives for smart healthcare to boost market 339
16.6.2.4 Rest of GCC 345
16.6.2.4.1 Increasing healthcare digitization to drive market 345
16.6.3 SOUTH AFRICA 351
16.6.3.1 Growing adoption and readiness for AI-enabled medical imaging to boost market 351
16.6.4 REST OF MIDDLE EAST & AFRICA 356
17 COMPETITIVE LANDSCAPE 363
17.1 INTRODUCTION 363
17.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 363
17.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 364
17.3 REVENUE ANALYSIS, 2021–2025 366
17.4 MARKET SHARE ANALYSIS, 2025 367
17.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 370
17.5.1 STARS 370
17.5.2 EMERGING LEADERS 370
17.5.3 PERVASIVE PLAYERS 371
17.5.4 PARTICIPANTS 371
17.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 373
17.5.5.1 Company footprint 373
17.5.5.2 Region footprint 374
17.5.5.3 Type footprint 375
17.5.5.4 Technology footprint 376
17.5.5.5 Image Type footprint 377
17.6 COMPANY EVALUATION MATRIX: STARTUPS /SMES, 2025 378
17.6.1 PROGRESSIVE COMPANIES 378
17.6.2 RESPONSIVE COMPANIES 378
17.6.3 DYNAMIC COMPANIES 378
17.6.4 STARTING BLOCKS 379
17.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 380
17.6.5.1 Detailed list of key startups/SMEs 380
17.6.5.2 Competitive benchmarking of key startups/SMEs 380
17.7 COMPANY VALUATION AND FINANCIAL METRICS 381
17.8 BRAND/SOFTWARE COMPARISON 382
17.9 COMPETITIVE SCENARIO 383
17.9.1 PRODUCT/SERVICE LAUNCHES & UPGRADES 383
17.9.2 DEALS 383
17.9.3 EXPANSIONS 384
18 COMPANY PROFILES 385
18.1 KEY PLAYERS 385
18.1.1 SIEMENS HEALTHINEERS AG 385
18.1.1.1 Products/solutions/services offered 386
18.1.1.2 Recent developments 388
18.1.1.2.1 Product launches & upgrades 388
18.1.1.2.2 Deals 388
18.1.1.2.3 Expansions 389
18.1.1.3 MnM view 389
18.1.1.3.1 Key strengths 389
18.1.1.3.2 Strategic choices 389
18.1.1.3.3 Weaknesses and competitive threats 389
18.1.2 GE HEALTHCARE 390
18.1.2.1 Business overview 390
18.1.2.2 Products/solutions/services offered 391
18.1.2.3 Recent developments 392
18.1.2.3.1 Product launches & upgrades 393
18.1.2.3.2 Deals 394
18.1.2.4 MnM view 395
18.1.2.4.1 Key strengths 395
18.1.2.4.2 Strategic choices 395
18.1.2.4.3 Weaknesses and competitive threats 395
18.1.3 KONINKLIJKE PHILIPS N.V. 396
18.1.3.1 Business overview 396
18.1.3.2 Products/solutions/services offered 397
18.1.3.3 Recent developments 400
18.1.3.3.1 Product launches & upgrades 400
18.1.3.3.2 Deals 401
18.1.3.3.3 Expansions 401
18.1.3.4 MnM view 402
18.1.3.4.1 Key strengths 402
18.1.3.4.2 Strategic choices 402
18.1.3.4.3 Weaknesses and competitive threats 402
18.1.4 CANON MEDICAL SYSTEMS CORPORATION 403
18.1.4.1 Business overview 403
18.1.4.2 Products/solutions/services offered 404
18.1.4.3 Recent developments 406
18.1.4.3.1 Product launches & upgrades 406
18.1.4.3.2 Deals 406
18.1.5 FUJIFILM HOLDINGS CORPORATION 407
18.1.5.1 Business overview 407
18.1.5.2 Products/solutions/services offered 408
18.1.5.3 Recent developments 409
18.1.5.3.1 Product launches & upgrades 409
18.1.5.3.2 Deals 410
18.1.6 AGFA-GEVAERT N.V. 411
18.1.6.1 Business overview 411
18.1.6.2 Products/solutions/services offered 413
18.1.6.3 Recent developments 414
18.1.6.3.1 Product launches & upgrades 414
18.1.6.3.2 Deals 414
18.1.7 CARESTREAM HEALTH 416
18.1.7.1 Business overview 416
18.1.7.2 Products/solutions/services offered 416
18.1.7.3 Recent developments 417
18.1.7.3.1 Product launches & upgrades 417
18.1.7.3.2 Deals 418
18.1.8 HOLOGIC, INC. 419
18.1.8.1 Business overview 419
18.1.8.2 Products/solutions/services offered 419
18.1.8.3 Recent developments 420
18.1.8.3.1 Product launches & upgrades 420
18.1.8.3.2 Deals 421
18.1.9 MERATIVE 422
18.1.9.1 Business overview 422
18.1.9.2 Products/solutions/services offered 422
18.1.9.3 Recent developments 424
18.1.9.3.1 Product launches & upgrades 424
18.1.9.3.2 Deals 424
18.1.9.3.3 Expansions 424
18.1.10 SECTRA AB 425
18.1.10.1 Business overview 425
18.1.10.2 Products/solutions/services offered 426
18.1.10.3 Recent developments 428
18.1.10.3.1 Product launches & upgrades 428
18.1.10.3.2 Deals 428
18.1.11 BRUKER CORPORATION 430
18.1.11.1 Business overview 430
18.1.11.2 Products/solutions/services offered 431
18.1.12 QUIBIM 433
18.1.12.1 Business overview 433
18.1.12.2 Products/solutions/services offered 433
18.1.12.3 Recent developments 434
18.1.12.3.1 Deals 434
18.1.13 MIRADA MEDICAL LTD. 435
18.1.13.1 Business overview 435
18.1.13.2 Products/solutions/services offered 435
18.1.13.3 Recent developments 436
18.1.13.3.1 Products launches & upgrades 436
18.1.13.3.2 Deals 436
18.1.13.4 Other developments 437
18.1.14 MEDIAN TECHNOLOGIES 438
18.1.14.1 Business overview 438
18.1.14.2 Products/solutions/services offered 439
18.1.14.3 Recent developments 440
18.1.14.3.1 Products launches & upgrades 440
18.1.14.3.2 Deals 441
18.1.15 ELUCID 442
18.1.15.1 Business overview 442
18.1.15.2 Products/solutions/services offered 442
18.1.15.3 Recent developments 443
18.1.15.3.1 Products launches & upgrades 443
18.1.15.3.2 Other developments 443
18.1.16 RAPIDAI, INC. 444
18.1.16.1 Business overview 444
18.1.16.2 Products/solutions/services offered 445
18.1.16.3 Recent developments 446
18.1.16.3.1 Product launches & upgrades 446
18.1.16.3.2 Deals 447
18.1.17 MICROSOFT CORPORATION 448
18.1.17.1 Business overview 448
18.1.17.2 Products/solutions/services offered 449
18.1.17.3 Recent developments 450
18.1.17.3.1 Product launches & upgrades 450
18.1.17.3.2 Deals 451
18.1.18 TEMPUS AI, INC. 453
18.1.18.1 Business overview 453
18.1.18.2 Products/solutions/services offered 454
18.1.18.3 Recent developments 455
18.1.18.3.1 Product launches & upgrades 455
18.1.18.3.2 Deals 456
18.1.19 NANO-X IMAGING LTD 457
18.1.19.1 Business overview 457
18.1.19.2 Products/solutions/services offered 458
18.1.19.3 Recent developments 459
18.1.19.3.1 Product launches & upgrades 459
18.1.19.3.2 Deals 460
18.1.20 CONTEXTVISION AB 461
18.1.20.1 Business overview 461
18.1.20.2 Products/solutions/services offered 462
18.1.20.3 Recent developments 463
18.1.20.3.1 Product launches & upgrades 463
18.1.20.3.2 Deals 463
18.2 OTHER PLAYERS 465
18.2.1 VIZ.AI, INC. 465
18.2.2 AIDOC MEDICAL LTD. 466
18.2.3 AVICENNA.AI 466
18.2.4 CLEERLY, INC. 467
18.2.5 OVERJET, INC. 467
19 RESEARCH METHODOLOGY 468
19.1 RESEARCH APPROACH 468
19.1.1 SECONDARY RESEARCH 468
19.1.1.1 Key data from secondary sources 469
19.1.2 PRIMARY RESEARCH 470
19.1.2.1 Key data from primary sources 471
19.1.2.2 Insights from primary experts 472
19.2 RESEARCH METHODOLOGY DESIGN 473
19.3 MARKET SIZE ESTIMATION 474
19.4 MARKET BREAKDOWN DATA TRIANGULATION 479
19.5 MARKET SHARE ESTIMATION 480
19.6 STUDY ASSUMPTIONS 480
19.7 LIMITATIONS 481
19.7.1 SCOPE-RELATED LIMITATIONS 481
19.7.2 METHODOLOGY-RELATED LIMITATIONS 481
19.8 RISK ASSESSMENT 481
20 APPENDIX 482
20.1 DISCUSSION GUIDE 482
20.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 488
20.3 CUSTOMIZATION OPTIONS 490
20.4 RELATED REPORTS 490
20.5 AUTHOR DETAILS 491